The neuroprotective role of GLP1 in diabetic polyneuropathy and the influence of serotonin in cognitive decline post‐COVID‐19 further substantiate the significance of the brain–gut axis [36, 40]. This evidence concerns the gene GLP1R and diabetic neuropathy.